Microbion Corporation Announces Granting of a US Patent for the Use of Topical Pravibismane for Diabetic Foot Ulcer Infections
- Tuesday, March 15, 2022, 7:11
- Business
- Add a comment
Extends patent protection for Microbion’s proprietary topical pravibismane for the treatment of diabetic foot ulcer infections to 2039 BOZEMAN, Mont., and VANCOUVER, BC, March 15, 2022 /PRNewswire/ – Microbion Corporation today announced that the US Patent and Trademark Office (USPTO)…
About the Author
adminasapcorp has written 41821 stories on this site.